Results In 2010 were identified 269 pathogens in 409 NI. The distribution including all sites of infection was: Coagulase Negative Staphylococcus (CNS) 20,6%, Pseudomonas aeruginosa 15,9%, Staphylococcus aureus 15,9%, Candida sp 7,8%, Escherichia coli 7,8%, Klebsiella sp 7,8%, Enterococcus sp 5,7%, Enterobacter sp 5,4%, Acinetobacter baumanii 3,4% and other agents 9,7%. The Staphylococcus sp se...

CONTEXT Nosocomial infections are an important cause of morbidity and mortality after cardiac surgery. Decolonization of endogenous potential pathogenic microorganisms is important in the prevention of nosocomial infections. OBJECTIVE To determine the efficacy of perioperative decontamination of the nasopharynx and oropharynx with 0.12% chlorhexidine gluconate for reduction of nosocomial infe...

INTRODUCTION Methicillin-resistant Staphylococcus aureus (MRSA) is spread out in hospitals across different regions of the world and is regarded as the major agent of nosocomial infections, causing infections such as skin and soft tissue pneumonia and sepsis. The aim of this study was to identify risk factors for methicillin-resistance in Staphylococcus aureus bloodstream infection (BSI) and th...

Staphylococcus aureus causes a variety of suppurative (pus-forming) infections and toxinoses in humans. It causes superficial skin lesions such as boils, styes and furuncules; more serious infections such as pneumonia, mastitis, phlebitis, meningitis, and urinary tract infections; and deep-seated infections, such as osteomyelitis and endocarditis. S. aureus is a major cause of hospital acquired...

Between January 1997 and December 1999, bloodstream isolates from 15,439 patients infected with Staphylococcus aureus and 6350 patients infected with coagulase-negative Staphylococcus species (CoNS) were referred by SENTRY-participating hospitals in the United States, Canada, Latin America, Europe, and the Western Pacific region. S. aureus was found to be the most prevalent cause of bloodstream...

Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) are the main agents of nosocomial infections. The antimicrobial resistance of these microorganisms has increased worldwide, justified by the selective pressure caused by the use of broad spectrum antibiotics. The prophylactic antibioticotherapy is also a concerning factor, because it increases the risk of infection, and difficul...

The rate of nosocomial bacteremia due to Staphylococcus aureus has increased over the past decade, but trends in community-acquired S. aureus bacteremia are less certain. This hospital-based observational study compares nosocomial and community-acquired S. aureus bacteremias during 1980-1983 and 1990-1993. The rate of nosocomial S. aureus bacteremia increased from 0.75 to 2.80 cases per 1,000 d...

OBJECTIVE The present study was aimed at determining device-associated infection rates, device use rates and the microbiologic profile of nosocomial infections in a tertiary neonatal intensive care unit (ICU) in Bogotá, Colombia. METHODS Prospective nosocomial infection surveillance was implemented in a neonatal intensive care unit for 11 months in line with the High Risk Nursery component of...

Staphylococcus aureus is one of the most common causes of nosocomial pneumonia contributing to significant morbidity and mortality. Therapeutic options for patients with methicillin-resistant S. aureus (MRSA) infection are limited. In addition, little is known about the S. aureus virulence factors that may influence the presentation and prognosis of severe lower respiratory tract infections. An...

©2005 British Editorial Society of Bone and Joint Surgery doi:10.1302/0301-620X.87B6. 16292 $2.00 J Bone Joint Surg [Br] 2005;87-B:749-54. Methicillin-resistant Staphylococcus aureus (MRSA) has been an increasing problem since its isolation in England in 1961. 1 The publicity surrounding MRSA, and nosocomial infection in general, has never been greater. The introduction by the Department of Hea...